Lir Life Sciences Corp. (CVE:SKNY) | Finanzwire

Basculer en Français

10443	Companies
219236	Keywords
148695	Articles
115969	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 05/23/2026 at 01:05, 3 hours 1 minute ago

LIR Life Sciences Initiates Phase 1 Transdermal Delivery Development

Transdermal Delivery LIR Life Sciences Neuland Laboratories Phase 1 Development Macromolecule Synthesis
PRESS RELEASE

published on 05/23/2026 at 01:00, 3 hours 6 minutes ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Neuland Laboratories Limited orders raw materials for Phase 1 of macromolecule-enabled transdermal delivery development with LIR Life Sciences Corp. to advance needle-free, skin-applied peptide therapies

Phase 1 Lir Life Sciences Corp. Neuland Laboratories Limited Macromolecule-enabled Transdermal Delivery Needle-free Peptide Therapies
BRIEF

published on 04/29/2026 at 00:05, 24 days 4 hours ago

LIR Life Sciences Initiates Ex Vivo Study on Protamine's Efficacy in Transdermal Delivery

Ex Vivo Study Needle-free Delivery Protamine Enhancement Transdermal Transport Therapeutic Molecules
PRESS RELEASE

published on 04/29/2026 at 00:00, 24 days 4 hours ago

LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
LIR Life Sciences Corp. announces the launch of a controlled ex vivo porcine skin study to evaluate protamine's impact on transdermal movement of macromolecular therapeutics. The study aims to advance needle-free delivery options for larger molecules

Transdermal Delivery Lir Life Sciences Corp. Needle-free Delivery Protamine Macromolecular Therapeutics
BRIEF

published on 04/21/2026 at 00:05, 1 month 2 days ago

LIR Life Sciences Corp. Partners with Resilience BioSciences Inc.

Drug Development Preclinical Research Technology Collaboration Novel Therapies Academic Environment
PRESS RELEASE

published on 04/21/2026 at 00:00, 1 month 2 days ago

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
LIR Life Sciences Corp. announces a Technology Development Collaboration Agreement with Resilience BioSciences Inc. to enhance preclinical research activities in drug discovery and development

Drug Discovery Life Sciences Collaboration Agreement Preclinical Research Resilience BioSciences
BRIEF

published on 02/06/2026 at 00:05, 3 months 17 days ago

LIR Life Sciences Initiates Phase 2 Peptide Design with Neuland Laboratories

Transdermal Delivery LIR Life Sciences Neuland Laboratories Peptide Design Structure-Activity Relationships
PRESS RELEASE

published on 02/06/2026 at 00:00, 3 months 17 days ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
LIR Life Sciences Corp. announces commencement of Project Phase 2 peptide design activities with Neuland Laboratories Limited, focusing on next-generation cell-penetrating peptides for transdermal delivery platform optimization

Transdermal Delivery Lir Life Sciences Corp. Peptide Design Project Phase 2 Neuland Laboratories Limited
BRIEF

published on 01/30/2026 at 00:05, 3 months 24 days ago

LIR Life Sciences Reports Promising Interim Preclinical Results

Transdermal Delivery Preclinical Results GLP/GIP Therapies CPP Technology Blood Glucose Control
PRESS RELEASE

published on 01/30/2026 at 00:00, 3 months 24 days ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
LIR Life Sciences Corp. announces positive interim results from a mouse study on CPP-enabled, needle-free delivery of GLP/GIP therapies, demonstrating glucose control potential

Interim Results Lir Life Sciences Corp. GLP/GIP Therapies CPP-enabled Delivery Skin-applied Formulation

Accesswire

Published on 05/23/2026 at 03:15, 51 minutes ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 hour 6 minutes ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 hour 41 minutes ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 hour 41 minutes ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 3 hours 6 minutes ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

View all ACCESSWIRE

EQS Group

Published on 05/22/2026 at 22:05, 6 hours ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 8 hours 14 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 9 hours 33 minutes ago

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 9 hours 35 minutes ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 18:29, 9 hours 37 minutes ago

Designated Person Notification

Les Echos

Published on 05/22/2026 at 18:05, 10 hours ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 15 hours 13 minutes ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 19 hours 36 minutes ago

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:50, 1 day 10 hours ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 1 day 10 hours ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE